GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,425.00p
   
  • Change Today:
      19.00p
  • 52 Week High: 2,263.00
  • 52 Week Low: 1,400.00
  • Currency: UK Pounds
  • Shares Issued: 4,067.35m
  • Volume: 8,805,624
  • Market Cap: £57,960m
  • RiskGrade: 129

Latest ShareCast News

GSK to 'vigorously defend' Zantac claims; Haleon says not a party to claims

By Michele Maatouk

Date: Friday 12 Aug 2022

(Sharecast News) - GlaxoSmithKline said on Friday that it would "vigorously defend" all claims related to its discontinued heartburn drug Zantac.

GSK ShareCast News

GSK, Haleon, Sanofi slump amid Zantac litigation... 11-Aug-2022 ShareCast
GSK lifts full-year outlook as Q2 sales rise 27-Jul-2022 ShareCast
Citi starts GSK spinoff Haleon at 'buy' 21-Jul-2022 ShareCast
GSK spins off consumer healthcare giant Haleon 18-Jul-2022 ShareCast
Covid-19 cases surge during latest week due to B... 01-Jul-2022 ShareCast

GSK Regulatory News

GSK completes acquisition of Affinivax, Inc. 16-Aug-2022 07:06 RNS
Statement: Zantac (ranitidine) litigation 12-Aug-2022 07:00 RNS
Director/PDMR Shareholding 11-Aug-2022 11:51 RNS
Director/PDMR Shareholding 10-Aug-2022 16:57 RNS
Total Voting Rights 01-Aug-2022 18:10 RNS

GSK Newspaper Links

GSK and Haleon lose billions in value as investo... 12-Aug-2022 Times
GlaxoSmithKline scraps sale of old drugs 05-Dec-2014 Telegraph
Glaxo sharpens axe to save £1bn as insurers and ... 01-Dec-2014 The Independent
GSK to cut hundreds of US jobs 01-Dec-2014 Telegraph
Ebola vaccine trials 'encouraging', says GSK 27-Nov-2014 Telegraph

GSK Tips & Analysis

Questor :GlaxoSmithKline 16-Apr-2014 Telegraph
Questor:GlaxoSmithKline 06-Oct-2011 Telegraph
Questor:GlaxoSmithKline 11-Aug-2011 Telegraph
Questor tip: GlaxoSmithKline 28-Jul-2011 Telegraph
Investment Column: GlaxoSmithKline 27-Jul-2011 The Independent

GSK News Wires

FDA Approves Promacta(R) (Eltrombopag), the Firs... 20-Nov-2008 PR Newswire
Study Found That Long Term Use of Advair Diskus(... 29-Oct-2008 PR Newswire
GlaxoSmithKline to Acquire Genelabs Technologies... 29-Oct-2008 PR Newswire
A New Interactive Consumer Experience Highlighti... 28-Sep-2007 PR Newswire
AUDIO from Medialink and GlaxoSmithKline: A New ... 28-Sep-2007 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,425.00p
Change Today 19.00p
% Change 1.35 %
52 Week High 2,263.00
52 Week Low 1,400.00
Volume 8,805,624
Shares Issued 4,067.35m
Market Cap £57,960m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
60.44% below the market average60.44% below the market average60.44% below the market average60.44% below the market average60.44% below the market average
1.59% below the sector average1.59% below the sector average1.59% below the sector average1.59% below the sector average1.59% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 7
Buy 1
Neutral 13
Sell 0
Strong Sell 1
Total 22
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q2 Q1
Ex-Div 18-Aug-22 19-May-22
Paid 06-Oct-22 01-Jul-22
Amount 16.25p 14.00p

Trades for 16-Aug-2022

Time Volume / Share Price
17:11 7,366 @ 1,425.76p
17:11 35,232 @ 1,428.07p
17:11 29,594 @ 1,424.99p
17:11 37,725 @ 1,429.68p
17:11 19,687 @ 1,435.27p

GSK Key Personnel

CEO Emma Walmsley
CFO Iain Mackay

Top of Page